Vimarsana
Biggest News Aggregation in the World

Page 7 - Partner Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Partner Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Partner Programs Today - Breaking & Trending Today

Hexaware Achieves the Guidewire Rapid Implementation Specialization - Vimarsana News

Hexaware Achieves the Guidewire Rapid Implementation Specialization

/PRNewswire/ -- Hexaware Technologies, a leading Global IT Consulting and Digital Solutions provider, today announced that it has achieved the Guidewire...

LTIMindtree achieves Guidewire PartnerConnect Program Specialization - Vimarsana News

LTIMindtree achieves Guidewire PartnerConnect Program Specialization

Edison (New Jersey) [US]/Mumbai (Maharashtra) [India], February 9 (ANI/BusinessWire India): LTIMindtree, a global technology consulting and digital solutions company, today announced that it has achieved the Guidewire PartnerConnect Testing Standards specialization

Save the Storks Equips Thousands of Women to Choose Life in 2022, Anticipates Growth in 2023 - Vimarsana News

Save the Storks Equips Thousands of Women to Choose Life in 2022, Anticipates Growth in 2023

/PRNewswire/ -- With the start of the new year, Save the Storks is reflecting on its impact in 2022 and looking forward to plans for 2023 that will continue to...

Save the Storks Equips Thousands of Women to Choose Life in 2022, Anticipates Growth in 2023 - Vimarsana News

Save the Storks Equips Thousands of Women to Choose Life in 2022, Anticipates Growth in 2023

/PRNewswire/ -- With the start of the new year, Save the Storks is reflecting on its impact in 2022 and looking forward to plans for 2023 that will continue to...

Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day - Vimarsana News

Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day

During the event, the Company plans to showcase its R&D progress and platform innovation, as well as its product and pipeline goals for 2023 focused on continued commercial execution of four RNAi therapeutic products, and advancement of early-, mid-, and late-stage investigational programs.